Societies

Moderna is exploring the potential of mRNA in immuno-oncology across various cancer types

Photo taken from Moderna/LinkedIn

Apr 9, 2024, 16:41

Moderna is exploring the potential of mRNA in immuno-oncology across various cancer types

Quoting Moderna on LinkedIn:

“Moderna is exploring the potential of mRNA in immuno-oncology across various cancer types, harnessing the body’s immune system to identify and kill cancer cells.

We believe the adaptability of mRNA technology can be leveraged to create an innovative and diverse portfolio of investigational cancer therapies, including individualized approaches.

Join us at AACR24 in San Diego at booth 441 as we continue to showcase the potential of mRNA technology and the possibility of changing cancer care and improving outcomes for patients.”

Source: Moderna/LinkedIn

AACR24 cancer Cancer research cancer therapies cancer treatment Innovation Medical Advancements Medical Technology mmuno-oncology Moderna mRNA OncoDaily Oncology San Diego

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage